197 related articles for article (PubMed ID: 24464802)
1. Indiplon is hydrolyzed by arylacetamide deacetylase in human liver.
Shimizu M; Fukami T; Ito Y; Kurokawa T; Kariya M; Nakajima M; Yokoi T
Drug Metab Dispos; 2014 Apr; 42(4):751-8. PubMed ID: 24464802
[TBL] [Abstract][Full Text] [Related]
2. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M
Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127
[TBL] [Abstract][Full Text] [Related]
3. Hydrolase activities of cynomolgus monkey liver microsomes and recombinant CES1, CES2, and AADAC.
Honda S; Fukami T; Tsujiguchi T; Zhang Y; Nakano M; Nakajima M
Eur J Pharm Sci; 2021 Jun; 161():105807. PubMed ID: 33722734
[TBL] [Abstract][Full Text] [Related]
4. Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase.
Shimizu M; Fukami T; Nakajima M; Yokoi T
Drug Metab Dispos; 2014 Jul; 42(7):1103-9. PubMed ID: 24751575
[TBL] [Abstract][Full Text] [Related]
5. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M
Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098
[TBL] [Abstract][Full Text] [Related]
6. Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liver.
Kobayashi Y; Fukami T; Shimizu M; Nakajima M; Yokoi T
Drug Metab Dispos; 2012 Jun; 40(6):1080-4. PubMed ID: 22446520
[TBL] [Abstract][Full Text] [Related]
7. A novel polymorphic allele of human arylacetamide deacetylase leads to decreased enzyme activity.
Shimizu M; Fukami T; Kobayashi Y; Takamiya M; Aoki Y; Nakajima M; Yokoi T
Drug Metab Dispos; 2012 Jun; 40(6):1183-90. PubMed ID: 22415931
[TBL] [Abstract][Full Text] [Related]
8. Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and Dog.
Kurokawa T; Fukami T; Yoshida T; Nakajima M
Drug Metab Dispos; 2016 Mar; 44(3):409-16. PubMed ID: 26718653
[TBL] [Abstract][Full Text] [Related]
9. Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse.
Kobayashi Y; Fukami T; Nakajima A; Watanabe A; Nakajima M; Yokoi T
Drug Metab Dispos; 2012 Apr; 40(4):671-9. PubMed ID: 22207054
[TBL] [Abstract][Full Text] [Related]
10. Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen.
Watanabe A; Fukami T; Takahashi S; Kobayashi Y; Nakagawa N; Nakajima M; Yokoi T
Drug Metab Dispos; 2010 Sep; 38(9):1532-7. PubMed ID: 20542992
[TBL] [Abstract][Full Text] [Related]
11. Role of Human Arylacetamide Deacetylase (AADAC) on Hydrolysis of Eslicarbazepine Acetate and Effects of
Hirosawa K; Fukami T; Tashiro K; Sakai Y; Kisui F; Nakano M; Nakajima M
Drug Metab Dispos; 2021 Apr; 49(4):322-329. PubMed ID: 33446525
[TBL] [Abstract][Full Text] [Related]
12. Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis.
Watanabe A; Fukami T; Nakajima M; Takamiya M; Aoki Y; Yokoi T
Drug Metab Dispos; 2009 Jul; 37(7):1513-20. PubMed ID: 19339378
[TBL] [Abstract][Full Text] [Related]
13. Differences in Hydrolase Activities in the Liver and Small Intestine between Marmosets and Humans.
Honda S; Fukami T; Hirosawa K; Tsujiguchi T; Zhang Y; Nakano M; Uehara S; Uno Y; Yamazaki H; Nakajima M
Drug Metab Dispos; 2021 Sep; 49(9):718-728. PubMed ID: 34135089
[TBL] [Abstract][Full Text] [Related]
14. Epicatechin gallate and epigallocatechin gallate are potent inhibitors of human arylacetamide deacetylase.
Yasuda K; Watanabe K; Fukami T; Nakashima S; Ikushiro SI; Nakajima M; Sakaki T
Drug Metab Pharmacokinet; 2021 Aug; 39():100397. PubMed ID: 34171773
[TBL] [Abstract][Full Text] [Related]
15. Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver.
Sato Y; Miyashita A; Iwatsubo T; Usui T
Drug Metab Dispos; 2012 May; 40(5):902-6. PubMed ID: 22293119
[TBL] [Abstract][Full Text] [Related]
16. Arylacetamide deacetylase as a determinant of the hydrolysis and activation of abiraterone acetate in mice and humans.
Sakai Y; Fukami T; Nagaoka M; Hirosawa K; Ichida H; Sato R; Suzuki K; Nakano M; Nakajima M
Life Sci; 2021 Nov; 284():119896. PubMed ID: 34450168
[TBL] [Abstract][Full Text] [Related]
17. N-Glycosylation during translation is essential for human arylacetamide deacetylase enzyme activity.
Muta K; Fukami T; Nakajima M; Yokoi T
Biochem Pharmacol; 2014 Jan; 87(2):352-9. PubMed ID: 24125761
[TBL] [Abstract][Full Text] [Related]
18. Strain and sex differences in drug hydrolase activities in rodent livers.
Kisui F; Fukami T; Nakano M; Nakajima M
Eur J Pharm Sci; 2020 Jan; 142():105143. PubMed ID: 31726091
[TBL] [Abstract][Full Text] [Related]
19. Identification of enzymes responsible for nitrazepam metabolism and toxicity in human.
Konishi K; Fukami T; Gotoh S; Nakajima M
Biochem Pharmacol; 2017 Sep; 140():150-160. PubMed ID: 28606603
[TBL] [Abstract][Full Text] [Related]
20. Carboxylesterases and arylacetamide deacetylase comparison in human A549, H460, and H727 pulmonary cells.
Gabriele M; Puccini P; Gervasi PG; Longo V
Life Sci; 2021 Jul; 277():119486. PubMed ID: 33864822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
